Centiva Capital’s Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 SHAP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75,000
Closed -$9K 1918
2022
Q2
$9K Hold
75,000
﹤0.01% 1546
2022
Q1
$14K Buy
+75,000
New +$17.8K ﹤0.01% 1513

Other funds holding SHAP.WS

Centiva Capital's SHAP.WS Position: Q3 2022 in Review

Centiva Capital sold out of Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (SHAP.WS) in Q3 2022, closing a stake of 75,000 shares — an estimated $9K sold.

Centiva Capital first reported a position in SHAP.WS in Q1 2022 and held it in 2 quarters. The position peaked at $14K in Q1 2022. 33 funds tracked by Wall St. Rank hold SHAP.WS as of Q3 2022.

  • Centiva Capital reported no remaining Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Centiva Capital sold 75,000 Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $9K.
  • Centiva Capital first reported a position in Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Centiva Capital's Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $14K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Centiva Capital's 13F filing for Q3 2022, filed 14 Nov 2022.